Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3216873
Max Phase: Preclinical
Molecular Formula: C22H29Cl2N9O4
Molecular Weight: 481.52
Molecule Type: Small molecule
Associated Items:
ID: ALA3216873
Max Phase: Preclinical
Molecular Formula: C22H29Cl2N9O4
Molecular Weight: 481.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Cl.Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC=O)cn3C)cn2C)cc1C(=O)NCCC(=N)N
Standard InChI: InChI=1S/C22H27N9O4.2ClH/c1-29-9-13(26-12-32)6-17(29)21(34)28-15-8-18(31(3)11-15)22(35)27-14-7-16(30(2)10-14)20(33)25-5-4-19(23)24;;/h6-12H,4-5H2,1-3H3,(H3,23,24)(H,25,33)(H,26,32)(H,27,35)(H,28,34);2*1H
Standard InChI Key: SLFBHJZSKXPYCM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 481.52 | Molecular Weight (Monoisotopic): 481.2186 | AlogP: 0.83 | #Rotatable Bonds: 10 |
Polar Surface Area: 181.06 | Molecular Species: BASE | HBA: 8 | HBD: 6 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 12.55 | CX LogP: -1.08 | CX LogD: -3.35 |
Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.14 | Np Likeness Score: -0.38 |
1. Bialer M, Yagen B, Mechoulam R, Becker Y.. (1980) Structure-activity relationships of pyrrole amidine antiviral antibiotics. 2. Preparation of mono- and tripyrrole derivatives of congocidine., 23 (10): [PMID:6252323] [10.1021/jm00184a018] |
2. Lown JW, Krowicki K, Balzarini J, De Clercq E.. (1986) Structure-activity relationship of novel oligopeptide antiviral and antitumor agents related to netropsin and distamycin., 29 (7): [PMID:3027326] [10.1021/jm00157a016] |
3. Baraldi PG, Beria I, Cacciari B, Cozzi P, Franzetti C, Mongelli N, Romagnoli R, Spalluto G. (1996) Synthesis and antitumor activity of novel distamycin derivatives, 6 (11): [10.1016/0960-894X(96)00204-1] |
4. Baraldi PG, Romagnoli R, Duatti A, Bolzati C, Piffanelli A, Bianchi N, Mischiati C, Gambari R.. (2000) Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents., 10 (12): [PMID:10890173] [10.1016/s0960-894x(00)00250-x] |
5. Parrick J, Porssa M, Davies LK, Dennis MF, Patel KB, Stratford MR, Wardman P. (1993) Targeting radiosensitizers to DNA by minor groove binding: nitroarenes based on netropsin and distamycin, 3 (8): [10.1016/S0960-894X(00)80045-1] |
6. Baraldi PG, Del Carmen Nunez M, Tabrizi MA, De Clercq E, Balzarini J, Bermejo J, Estévez F, Romagnoli R.. (2004) Design, synthesis, and biological evaluation of hybrid molecules containing alpha-methylene-gamma-butyrolactones and polypyrrole minor groove binders., 47 (11): [PMID:15139766] [10.1021/jm031104y] |
7. Krowicki K, Balzarini J, De Clercq E, Newman RA, Lown JW.. (1988) Novel DNA groove binding alkylators: design, synthesis, and biological evaluation., 31 (2): [PMID:2828620] [10.1021/jm00397a012] |
8. Baraldi PG, Romagnoli R, Guadix AE, Pineda de las Infantas MJ, Gallo MA, Espinosa A, Martinez A, Bingham JP, Hartley JA.. (2002) Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin A., 45 (17): [PMID:12166936] [10.1021/jm011113b] |
9. Baraldi PG, Balboni G, Cacciari B, Guiotto A, Manfredini S, Romagnoli R, Spalluto G, Thurston DE, Howard PW, Bianchi N, Rutigliano C, Mischiati C, Gambari R.. (1999) Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1, 4]benzodiazepine and minor-groove-binding oligopyrrole carriers., 42 (25): [PMID:10602698] [10.1021/jm991033w] |
10. Lee M, White LA, Nobles JA, Forrow SM, Hartley JA. (1991) Synthesis and DNA binding properties of an amidine-linked and phenyl-containing analogue of distamycin A, 1 (11): [10.1016/S0960-894X(01)81158-6] |
11. PubChem BioAssay data set, |
12. Romagnoli R, Baraldi PG, Pavani MG, Fruttarolo F, Preti D, Bovero A, Tabrizi MA, Bianchi N, Gambari R. (2004) Design, Synthesis and Growth Inhibition Activity of Bis-Epoxyethyl Derivatives of Stallimycin Modified on the Amidino Moiety, 13 (5): [10.1007/s00044-004-0034-6] |
13. Bialer M, Yagen B, Mechoulam R, Becker Y.. (1979) Structure--activity relationships of pyrrole amidine antiviral antibiotics. 1. Modifications of the alkylamidine side chain., 22 (11): [PMID:230350] [10.1021/jm00197a004] |
Source(2):